Black Diamond Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $129k | 46k | 2.81 |
| 2023-03-31 | $69k | 37k | 1.89 |
| 2022-12-31 | $67k | 37k | 1.80 |
| 2022-06-30 | $251k | 102k | 2.46 |
| 2022-03-31 | $502k | 181k | 2.77 |
| 2021-12-31 | $704k | 132k | 5.33 |
| 2021-09-30 | $1.1M | 126k | 8.46 |
| 2021-03-31 | $2.1M | 85k | 24.26 |
| 2020-12-31 | $2.3M | 72k | 32.05 |
| 2020-09-30 | $238k | 7.9k | 30.23 |
| 2020-06-30 | $718k | 17k | 42.19 |